May 6, 2021

MWI Animal Health UK Integrates Buying Group Services to Enhance Customer Experience

MWI Buying Group, the largest GPO in the U.K., will provide streamlined offering to member practices

Conshohocken, Pa. – Today, MWI Animal Health UK, a part of AmerisourceBergen, announced it integrated two of its entities to create a single group purchasing organization (GPO), MWI Buying Group, that will better position the company to support independent veterinary practices’ evolving needs.
MWI Buying Group, which represents 630 member practices across the U.K. and Ireland, combines the portfolio of benefits and support solutions offered via the company’s two buying group entities—St. Francis Group and VetsWest—into a single platform. Through its new GPO service, which is the largest in the U.K., MWI will provide practices with a clearer list of benefits, transparent pricing and rebates and solutions to help simplify purchasing administration and business processes. 
“Now more than ever before, independent veterinary practices need access to resources and support that can help them overcome challenges so they can continue to operate their business and deliver high-quality care,” said David Tinsley, Managing Director of MWI Animal Health U.K. “Through MWI Buying Group, we will help practices protect profitability, reduce time spent on purchasing and business administration and maintain positive patient outcomes—both now and in the future.”
Practices can also enroll in MWI Distinct Advantage, a membership program within the GPO service that offers a range of support, from business performance solutions like flexible payment terms and enhanced manufacturer rebates to resources that help support positive patient outcomes. 
The announcement comes about five years after MWI acquired St. Francis Group, an animal health buying group, in 2016. MWI acquired VetsWest, a leading veterinary support services provider, in August 2015. 
For more information about MWI Buying Group, please visit


About AmerisourceBergen                 
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, we create unparalleled access, efficiency, and reliability for human and animal health. Our 22,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 with more than $185 billion in annual revenue. Learn more at